DE602005025404D1 - Impfstoff gegen pasteurella multocida - Google Patents

Impfstoff gegen pasteurella multocida

Info

Publication number
DE602005025404D1
DE602005025404D1 DE602005025404T DE602005025404T DE602005025404D1 DE 602005025404 D1 DE602005025404 D1 DE 602005025404D1 DE 602005025404 T DE602005025404 T DE 602005025404T DE 602005025404 T DE602005025404 T DE 602005025404T DE 602005025404 D1 DE602005025404 D1 DE 602005025404D1
Authority
DE
Germany
Prior art keywords
pasteurella multocida
bacteria
vaccinate against
against pasteurella
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005025404T
Other languages
English (en)
Inventor
Yugang Luo
Paul Vermeij
Antonius Arnoldus Jacobs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of DE602005025404D1 publication Critical patent/DE602005025404D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE602005025404T 2004-12-22 2005-12-21 Impfstoff gegen pasteurella multocida Active DE602005025404D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63944704P 2004-12-22 2004-12-22
PCT/EP2005/056995 WO2006122586A1 (en) 2004-12-22 2005-12-21 Pasteurella multocida vaccine

Publications (1)

Publication Number Publication Date
DE602005025404D1 true DE602005025404D1 (de) 2011-01-27

Family

ID=36677027

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005025404T Active DE602005025404D1 (de) 2004-12-22 2005-12-21 Impfstoff gegen pasteurella multocida

Country Status (14)

Country Link
US (1) US8309101B2 (de)
EP (1) EP1831248B1 (de)
JP (1) JP4981684B2 (de)
KR (1) KR20070092290A (de)
CN (1) CN101087803B (de)
AT (1) ATE491720T1 (de)
AU (1) AU2005331860B2 (de)
BR (1) BRPI0519381A2 (de)
CA (1) CA2591624A1 (de)
DE (1) DE602005025404D1 (de)
MX (1) MX2007007570A (de)
RU (1) RU2415926C2 (de)
WO (1) WO2006122586A1 (de)
ZA (1) ZA200705087B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008118902A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
CN101948791A (zh) * 2010-09-21 2011-01-19 华东理工大学 一种溶藻弧菌野生毒株的无标记基因缺失减毒突变株、相关制剂及应用
RU2455024C1 (ru) * 2010-12-30 2012-07-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи Министерства здравоохранения и социального развития РФ" Аттенуированные бактерии bordetella pertussis, вакцина против возбудителя коклюша
RU2460791C1 (ru) * 2011-07-28 2012-09-10 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Способ аттенуации вакцинного туляремийного штамма
US20140147475A1 (en) * 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
ES2771473T3 (es) 2013-03-18 2020-07-06 Intervet Int Bv Vacuna para proteger a un rumiante contra la neumonía causada por Mannheimia haemolytica
WO2015066292A1 (en) 2013-11-01 2015-05-07 Merial Limited Attenuated pasteurella multocidavaccines & methods of making & use thereof
CN104560854B (zh) * 2015-01-07 2018-03-02 四川农业大学 缺失phoP的禽多杀性巴氏杆菌减毒菌株及其构建方法和应用
CN106114241A (zh) * 2016-06-28 2016-11-16 无锡新大力电机有限公司 一种含有冷却水套的太阳能电动汽车
CN109847060A (zh) * 2019-04-19 2019-06-07 黑龙江八一农垦大学 牛多杀性巴氏杆菌病、溶血性曼氏杆菌病二联灭活疫苗及其制备方法
CN110205395A (zh) * 2019-06-17 2019-09-06 武汉科前生物股份有限公司 副猪嗜血杆菌的血清分型方法、引物组合以及pcr体系

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994011024A1 (en) * 1992-11-06 1994-05-26 Regents Of The University Of Minnesota Composition protective against p. multocida pasteurellosis infection
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
ES2346915T3 (es) * 2002-04-05 2010-10-21 Merial Bacterias gram negativas atenuadas.
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria

Also Published As

Publication number Publication date
JP2008523840A (ja) 2008-07-10
EP1831248B1 (de) 2010-12-15
AU2005331860B2 (en) 2011-08-11
JP4981684B2 (ja) 2012-07-25
CN101087803A (zh) 2007-12-12
RU2415926C2 (ru) 2011-04-10
CN101087803B (zh) 2012-01-18
US8309101B2 (en) 2012-11-13
ZA200705087B (en) 2008-08-27
MX2007007570A (es) 2007-07-24
BRPI0519381A2 (pt) 2009-01-20
ATE491720T1 (de) 2011-01-15
WO2006122586A1 (en) 2006-11-23
CA2591624A1 (en) 2006-11-23
US20100062017A1 (en) 2010-03-11
EP1831248A1 (de) 2007-09-12
RU2007128047A (ru) 2009-01-27
KR20070092290A (ko) 2007-09-12
AU2005331860A1 (en) 2006-11-23

Similar Documents

Publication Publication Date Title
DE602005025404D1 (de) Impfstoff gegen pasteurella multocida
BRPI0508064A (pt) flavivìrus, composição de vacina e molécula de ácido nucléico
AR061246A1 (es) Anticuerpos anti- dill4 y metodos que los usan
MX341204B (es) Metodo para caracterizar almenos un microorganismo por medio de espectrometria de masa.
BR112015022934A2 (pt) esteroides neuroativos, composições, e uso do mesmo
CY1113738T1 (el) Εμβολια κατα της γριπης χαμηλης περιεκτικοτητας σε προσθετα
ATE497492T1 (de) Reinigung von montelukast
ATE503770T1 (de) Humane monoklonale antikörper gegen hendra- und nipah-viren
TW200740458A (en) Vaccination against dengue virus infection
SG153829A1 (en) Identifying virally infected and vaccinated organisms
ATE556717T1 (de) Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus
GEP20125595B (en) Milnacipran for long-term treatment of fibromyalgia syndrome
ATE414535T1 (de) Trägerproteine für impfstoffe
CY1116089T1 (el) Cd73 ως ενας βιοδεικτης για την παρακολουθηση της εξελιξης νοσων και εκτιμηση της αποτελεσματικοτητας θεραπειων
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
AR059851A1 (es) Anticuerpos de la egfl7 y metodos de uso
AR059096A1 (es) Anticuerpos anti- efrina -b2 y metodos que usan estos
MX2009003301A (es) Novedoso inmunogeno neutralizante (nimiv) de rhinovirus y su uso para aplicaciones de vacunas.
CL2008000856A1 (es) Uso de una pasteurella multocida mutante acapsular y atenuada para inducir inmunidad protectora cruzada en un animal contra p. multocida virulenta que tiene un serotipo diferente al de p. multocida mutante.
ATE504598T1 (de) Cspcna-isoform-modifikationen und anwendungen davon
EA201270390A1 (ru) 1,2,4-триазин, который может быть использован в качестве ускорителя вулканизации, и способ его получения
MX2013004069A (es) Antigenos inmunoreactivos de mycoplasma haemofelis e inmunoensayos de diagnostico.
ATE535253T1 (de) Impfstoff gegen mycoplasma prrsv
ATE424844T1 (de) Kombinationsvakzine für geflügel
WO2008133645A3 (en) Combination vaccine for prevention of tularemia